SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                  FORM 10-QSB/A


[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

                  For the quarterly period ended March 31, 2005

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the transition period from _______________ to _________________


                        Commission file number: 000-32253

                               SECURED DATA, INC.
                               ------------------
                      (formerly known As Secured Data, Inc.
           (Name of Small Business Issuer as specific in its Charter)

           Nevada                                        87-0650264
-------------------------------             ------------------------------------
(State or Other Jurisdiction of             (I.R.S. Employer Identification No.)
 Incorporation or Organization)

                   16B/F Ruixin Road Bldg. No. 25 Gaoxin Road
                      Xi An 710075 Shaanxi Province, China
              -----------------------------------------------------
           (Address of Principal Executive Offices Including Zip Code)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. [X] Yes [ ] No

The number of shares outstanding of the registrant's common equity as of May 18,
2005, was 93,604,958 shares of common stock, par value $0.001.

Transitional Small Business Disclosure Format (Check one): [ ] Yes [X] No


                                       1
<PAGE>

                               SECURED DATA, INC.
                            INDEX TO THE FORM 10-QSB
                    FOR THE THREE MONTHS ENDED MARCH 31, 2005


                                TABLE OF CONTENTS


PART I.  FINANCIAL INFORMATION                                                 3

Item 1.  Financial Statements                                                  3

            Balance Sheet as of March 31, 2005 (unaudited)                     3

            Statements  of  Operations  for the  three-month  period Ended
            March 31, 2005 (unaudited)                                         4

            Statements of Cash Flows for the three-months  ended March 31,
            2005 (unaudited)                                                   5

            Notes to the Financial Statements                                  6

Item 2.  Management's Discussion and Analysis or Plan of Operation            15

Item 3.  Controls and Procedures                                              21

PART II. OTHER INFORMATION                                                    22

Item 1.  Legal Proceedings                                                    22

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds          22

Item 3.  Defaults Upon Series Securities                                      22

Item 4.  Submission of Matters to a Vote of Security Holders                  22

Item 5.  Other Information                                                    23

Item 6:  Exhibits and Reports on Form 8-K                                     23

SIGNATURES                                                                    23


                                       2
<PAGE>

PART I.  FINANCIAL INFORMATION
Item 1.  Financial Statements

                       SECURED DATA, INC. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEET

<TABLE>
<CAPTION>
                                     ASSETS                            March 31, 2005     December 31,
                                                                         (Unaudited)          2004
                                                                        (As Restated)     (As Restated)
                                                                         -----------       -----------
<S>                                                                      <C>               <C>
CURRENT ASSETS
    Cash and cash equivalents                                            $   219,303       $   167,511
    Accounts receivable, net of allowances                                   504,967           104,144
    Inventories, net                                                       1,325,367         1,302,025
    Tax receivable                                                             3,407                --
    Due from stockholders                                                    272,324            62,493
    Deposits for investment                                                1,665,459                --
    Other assets                                                             371,054           335,058
                                                                         -----------       -----------
        Total Current Assets                                               4,361,881         1,971,231

PROPERTY AND EQUIPMENT, NET                                                  862,080           879,503

LAND USE RIGHTS, NET                                                         133,288           133,974

OTHER ASSETS
    Investment in affiliate                                                   31,078            31,190
                                                                         -----------       -----------
TOTAL ASSETS                                                             $ 5,388,327       $ 3,015,898
                                                                         ===========       ===========

                      LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
    Accounts payable                                                     $    77,562       $    56,454
    Other payables and accrued expenses                                      162,472           145,191
    Value added tax payables                                                      --            12,323
    Income tax and other tax payables                                          6,899             6,684
    Convertible note payable                                               1,900,000         1,900,000
    Due to stockholders                                                       73,868           193,433
                                                                         -----------       -----------
        Total Current Liabilities                                          2,220,801         2,314,085
                                                                         -----------       -----------

COMMITMENTS AND CONTINGENCIES                                                     --                --

MINORITY INTEREST                                                             56,832            58,915
                                                                         -----------       -----------

STOCKHOLDERS' EQUITY
    Preferred stock, $0.001 par value, 5,000,000 shares authorized,
        none issued and outstanding                                               --                --
    Common stock, $0.001 par value, 100,000,000 shares authorized,
        93,604,958 shares issued and outstanding                              93,605            93,605
    Additional paid-in capital                                             4,998,849         2,583,391
    Retained earnings (deficit)
      Unappropriated                                                      (1,989,010)       (2,041,348)
      Appropriated                                                             7,250             7,250
                                                                         -----------       -----------
        Total Stockholders' Equity                                         3,110,694           642,898
                                                                         -----------       -----------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                               $ 5,388,327       $ 3,015,898
                                                                         ===========       ===========
</TABLE>

    The accompanying notes are an integral part of these financial statements


                                       3
<PAGE>

                       SECURED DATA, INC. AND SUBSIDIARIES
         CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
                                  (UNAUDITED)

<TABLE>
<CAPTION>
                                                                      For the Three       For the Three
                                                                       Months Ended       Months Ended
                                                                      March 31, 2005     March 31, 2004
                                                                       ------------       ------------
<S>                                                                    <C>                <C>
NET SALES                                                              $    926,538       $    533,619

COST OF SALES                                                              (816,815)          (462,086)
                                                                       ------------       ------------

GROSS PROFIT                                                                109,723             71,533
                                                                       ------------       ------------

OPERATING EXPENSES
    Selling expenses and distribution expenses                               16,394              7,522
    General and administrative expenses                                      42,076              8,800
    Depreciation and amortization                                            17,393             12,987
                                                                       ------------       ------------
           Total Operating Expenses                                          75,863             29,309
                                                                       ------------       ------------

INCOME FROM OPERATIONS                                                       33,860             42,224

OTHER INCOME (EXPENSE)
    Equity in loss of affiliate                                                (112)                --
    Interest income, net                                                         49                166
    Other income (expense), net                                              42,270             (1,107)
                                                                       ------------       ------------
           Total Other Income (expense)                                      42,207               (941)

                                                                       ------------       ------------
PROFIT FROM OPERATIONS BEFORE TAXES AND MINORITY INTEREST                    76,067             41,283

INCOME TAX EXPENSE                                                          (25,812)           (14,049)

MINORITY INTEREST                                                             2,083              2,110
                                                                       ------------       ------------

NET INCOME                                                                   52,338             29,344

OTHER COMPREHENSIVE  INCOME
    Foreign currency translation loss                                            --                 --
                                                                       ------------       ------------

COMPREHENSIVE INCOME                                                   $     52,338       $     29,344
                                                                       ============       ============

Net income per share-diluted                                           $         --       $         --
                                                                       ============       ============

Weighted average number of shares outstanding during the period -
    diluted                                                              93,604,958         80,735,590
                                                                       ============       ============
</TABLE>
    The accompanying notes are an integral part of these financial statements


                                       4
<PAGE>

                       SECURED DATA, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
       FOR THE THREE MONTHS ENDED MARCH 31, 2005 (UNAUDITED AND RESTATED)

<TABLE>
<CAPTION>
                                                                                 Additional Unappropriated Appropriated
                                   Preferred Stock             Common Stock        paid-in     retained      retained
                                Shares       Amount      Shares        Amount      capital      deficit      earnings      Total
                             -----------  -----------  -----------  -----------  -----------  -----------   -----------  -----------
<S>                          <C>          <C>          <C>              <C>     <C>          <C>                 <C>      <C>
Balance at December 31, 2004          --           --   93,604,958       93,605    2,583,391   (2,041,348)        7,250      642,898

Registered capital
  appropriation                                                 --           --    2,415,458           --            --    2,415,458

Net income for the period                                       --           --           --       52,338            --       52,338
                             -----------  -----------  -----------  -----------  -----------  -----------   -----------  -----------
Balance at March 31, 2005             --  $        --   93,604,958       93,605  $ 4,998,849  $(1,989,010)        7,250    3,110,694
                             ===========  ===========  ===========  ===========  ===========  ===========   ===========  ===========
</TABLE>

    The accompanying notes are an integral part of these financial statements


                                       5
<PAGE>


                       SECURED DATA, INC. AND SUBSIDIARIES
                CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

<TABLE>
<CAPTION>
                                                                        For the Three       For the Three
                                                                         Months Ended       Months Ended
                                                                        March 31, 2005     March 31, 2004
                                                                          -----------       -----------
<S>                                                                       <C>               <C>
CASH FLOWS FROM OPERATING ACTIVITIES
    Net income                                                            $    52,338       $    29,344
    Adjusted to reconcile net loss to cash provided
       by (used in) operating activities:
       Depreciation and amortization - cost of sales                           56,221            17,167
       Depreciation and amortization                                           17,393            12,987
       Equity in loss of affiliate                                                112                --
       Minority interest                                                       (2,083)           (2,110)
    Changes in operating assets and liabilities (Increase) decrease in:
       Accounts receivable                                                   (400,823)           87,860
       Inventories                                                            (23,342)          110,539
       Tax receivable                                                          (3,407)               --
       Other receivables                                                      (35,996)         (611,552)
       Increase (decrease) in:
       Accounts payable                                                        21,108              (837)
       Other payables and accrued expenses                                     17,281            13,784
       Value added tax payables                                               (12,323)           40,085
       Income tax and other taxes payable                                         215             8,337
                                                                          -----------       -----------
       Net cash used in operating activities                                 (313,306)         (294,396)
                                                                          -----------       -----------

CASH FLOWS FROM INVESTING ACTIVITIES
    Decrease in notes receivable                                                   --           506,774
    (Increase) decrease in due from stockholders                             (209,831)              249
    Increase in due from an associate                                      (1,665,459)               --
    Purchase of property and equipment                                        (55,505)           (1,779)
                                                                          -----------       -----------
       Net cash (used in) provided by investing activities                 (1,930,795)          505,244
                                                                          -----------       -----------

CASH FLOWS FROM FINANCING ACTIVITIES
    Registered capital appropriation                                        2,415,458                --
    Decrease in notes payable                                                      --          (241,642)
    Decrease in due to stockholders                                          (119,565)               --
                                                                          -----------       -----------
       Net cash provided by (used in) financing activities                  2,295,893          (241,642)
                                                                          -----------       -----------

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                           51,792           (30,794)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD                              167,511            95,803
                                                                          -----------       -----------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                                $   219,303       $    65,009
                                                                          ===========       ===========

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

Cash paid during the period for:
    Income taxes                                                          $        --       $        --
                                                                          ===========       ===========

    Interest expenses                                                     $        --       $        --
                                                                          ===========       ===========
</TABLE>
    The accompanying notes are an integral part of these financial statements


                                       6
<PAGE>

                       SECURED DATA, INC. AND SUBSIDIARIES
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                  AS OF MARCH 31, 2005 (UNAUDITED AND RESTATED)


1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

      (A)   Organization

            Secured Data, Inc.  ("Secured  Data") was  incorporated in Nevada on
            March 16, 2000 under the name  Enternet,  Inc. On May 23, 2002,  the
            Articles  of  Incorporation  were  amended to change the name of the
            Company to Secured Data, Inc.

            Northwest  Bio-Technic  Inc.  ("Northwest")  was incorporated in the
            British  Virgin  Islands  ("BVI")  on June 25,  2004.  Xian  Huifeng
            Biochemistry  Joint-Stock  Company Limited ("Huifeng  Biochemistry")
            was  incorporated  in the  People's  Republic  of China  ("PRC")  on
            January  20,  2000 as a company  with  limited  liabilities  and was
            restructured  as a joint stock  company on September  29, 2002 under
            the laws of the PRC.

            Huifeng  Biochemistry   produces  plant  extracts  and  bio-chemical
            products  used as  pharmaceutical  raw materials in the PRC. Most of
            its  products  are  distributed  within  the PRC and  some  European
            countries.

            On August 23, 2001,  Huifeng  Biochemistry  established  a 70% owned
            subsidiary,  Xian Huifeng  Biochemistry  Engineering Company Limited
            ("Huifeng  Engineering")  in the PRC with a  registered  capital  of
            $265,778. The subsidiary has no operations since its incorporation.

            On June 16, 2004 Huifeng Biochemistry  acquired an 86.7% interest in
            Baoji Jinsen Pharmaceutical  Company Limited,  later renamed to Xian
            Huifeng Pharmaceutical Company Limited ("Huifeng Pharmaceutical"), a
            limited  liability  company in the PRC. On November 10, 2004 Huifeng
            Pharmaceutical  increased  its  registered  capital from $181,159 to
            $603,865. The increased registered capital was fully subscribed by a
            stockholder  of the  Company,  diluting  the  Company's  interest in
            Huifeng Pharmaceutical from 86.7% to 26%.

            During 2004, Huifeng  Biochemistry's  shareholders exchanged 100% of
            their  ownership  of  Huifeng  Biochemistry  for  500,000  shares of
            Northwest  under  a  reorganization  plan.  The  transfer  has  been
            accounted for as a  reorganization  of entities under common control
            as the companies were  beneficially  owned by principally  identical
            shareholders and share common management.

            On December  20, 2004,  pursuant to a Stock  Purchase  Agreement,  a
            Secured Data  shareholder  sold 7,229,601  shares in Secured Data to
            two Northwest  shareholders for $300,000.  On the same date, Secured
            Data entered into an Agreement and Plan of  Reorganization  with the
            shareholders of Northwest to exchange 30% of Northwest's outstanding
            shares for  80,735,590  shares of Secured  Data.  In  addition,  the
            Agreement  calls for Secured Data to issue a Convertible  Promissory
            Note for $1,900,000 that is convertible  into 10,465,725 (post a one
            for eighteen reverse split) shares of Secured Data for the remaining
            70% of Northwest.  As of May 15, 2005, the Convertible  Note has not
            been exercised.

            The merger of Secured  Data and  Northwest  has been  recorded  as a
            recapitalization  by Northwest,  with Northwest being treated as the
            continuing entity. The financial statements have been prepared as if
            the  reorganization  had  occurred   retroactively.   Secured  Data,
            Northwest,   Huifeng   Biochemistry  and  Huifeng   Engineering  are
            hereafter  referred to as (the  "Company").  The  transactions  were
            treated  for  accounting  purposes  as  a  capital  transaction  and
            recapitalization by the accounting  acquirer  ("Northwest") and as a
            reorganization by the accounting acquiree ("Secured Data").

            Accordingly, the financial statements include the following:

      (1)   The balance sheets as of March 31, 2005 (unaudited) and December 31,
            2004  consist of the net assets of the acquirer at  historical  cost
            and the net assets of the acquiree at historical cost.


                                       7
<PAGE>

      (2)   The  statement  of  operations  for the three months ended March 31,
            2005  (unaudited)  includes the  operations  of the acquirer for the
            periods  presented and the  operations of the acquiree from the date
            of the merger.

      (B)   Use of estimates

            The  preparation  of the financial  statements  in  conformity  with
            generally accepted accounting principles requires management to make
            estimates and assumptions  that affect the reported amount of assets
            and liabilities and disclosure of contingent  assets and liabilities
            at the date of the financial  statements and the reported amounts of
            revenues and expenses  during the reporting  period.  Actual results
            could differ from those estimates.

      (C)   Principles of consolidation

            The accompanying  consolidated  financial statements as of March 31,
            2005  (unaudited)  include the accounts of Secured Data and its 100%
            owned   subsidiary   Northwest,   100%  owned   subsidiary   Huifeng
            Biochemistry,  70%  owned  subsidiary  Huifeng  Engineering  and 26%
            investment  in Huifeng  Pharmaceutical  under the  equity  method of
            accounting. The accompanying financial statements as of December 31,
            2004  include  the  accounts  of  Secured  Data and its  100%  owned
            subsidiary  Northwest,  100% owned subsidiary Huifeng  Biochemistry,
            70% owned subsidiary Huifeng  Engineering and 86.7% owned subsidiary
            Huifeng  Pharmaceutical from the date of its acquisition on June 16,
            2004 to the date of its dilution in November  10, 2004.  The Company
            accounts for its investment in Huifeng  Pharmaceutical from November
            11, 2004 to December 31, 2004 under the equity method of accounting.
            Minority    interest    represents   the   minority    shareholders'
            proportionate    share   of   Huifeng    Engineering   and   Huifeng
            Pharmaceutical.   All   significant   inter-company   balances   and
            transactions have been eliminated in consolidation.

      (D)   Cash and cash equivalents

            For  purpose  of  the  statements  of  cash  flows,  cash  and  cash
            equivalents  include  cash on hand and demand  deposits  with a bank
            with a maturity of three months or less.

      (E)   Accounts receivable

            The  Company  extends  unsecured  credit  to  its  customers  in the
            ordinary  course of business but mitigates the  associated  risks by
            performing credit checks and actively pursuing past due accounts. An
            allowance for doubtful accounts is established and recorded based on
            managements'  assessment of the credit history with the customer and
            current  relationships  with them. As of March 31, 2005  (unaudited)
            the Company considers all its accounts  receivable to be collectable
            and  no  provision  for  doubtful  accounts  has  been  made  in the
            financial statements.

      (F)   Inventories

            Inventories  are stated at the lower of cost or market  value,  cost
            being  determined  on a first in,  first  out  method.  The  Company
            provides  for  inventory  allowances  based on excess  and  obsolete
            inventories determined principally by customer demand.

      (G)   Property and equipment

            Property  and  equipment  are  stated  at  cost,  less   accumulated
            depreciation.   Expenditures  for  additions,   major  renewals  and
            betterments  are capitalized  and  expenditures  for maintenance and
            repairs are charged to expense as incurred.

            Depreciation  is provided on a straight-line  basis,  less estimated
            residual  value  over  the  assets'   estimated  useful  lives.  The
            estimated useful lives are as follows:

            Plant and machinery                        10 Years

            Motor vehicles                             10 Years

            Furniture, fixtures and equipment           5 Years

            Land use rights are stated at cost, less  accumulated  amortization.
            The land use  rights  are  amortized  over the term of the  relevant
            rights of 50 years from the date of acquisition.


                                       8
<PAGE>

      (H)   Long-lived assets

            The Company  accounts for long-lived  assets under the Statements of
            Financial  Accounting  Standards  Nos. 142 and 144  "Accounting  for
            Goodwill and Other Intangible Assets" and "Accounting for Impairment
            or  Disposal  of  Long-Lived  Assets"  ("SFAS No. 142 and 144").  In
            accordance with SFAS No. 142 and 144,  long-lived  assets,  goodwill
            and  certain  identifiable  intangible  assets  held and used by the
            Company are reviewed for  impairment  whenever  events or changes in
            circumstances  indicate that the carrying amount of an asset may not
            be  recoverable.  For purposes of evaluating the  recoverability  of
            long-lived assets,  when undiscounted  future cash flows will not be
            sufficient  to  recover  an asset's  carrying  amount,  the asset is
            written down to its fair value.

      (I)   Fair value of financial instruments

            Statement of Financial  Accounting  Standards  No. 107,  "Disclosure
            About  Fair  Value  of  Financial   Instruments,"  requires  certain
            disclosures regarding the fair value of financial instruments.  Cash
            and cash equivalents,  accounts receivable,  other receivables,  tax
            receivable,  accounts  payable,  other  payables,  taxes payable and
            accrued  liabilities  are reflected in the  financial  statements at
            fair value because of the short-term maturity of the instruments.

      (J)   Revenue recognition

            The  Company  recognizes  revenue  upon  delivery or shipment of the
            products,  at which time title passes to the customer provided that:
            there are no uncertainties regarding customer acceptance; persuasive
            evidence  of an  arrangement  exists;  the  sales  price is fixed or
            determinable; and collectability is deemed probable.

      (K)   Income taxes

            The  Company  accounts  for  income  taxes  under the  Statement  of
            Financial  Accounting  Standards  No.  109,  "Accounting  for Income
            Taxes"  ("Statement  109"). Under Statement 109, deferred tax assets
            and  liabilities  are  recognized  for the future  tax  consequences
            attributable to differences between the financial statement carrying
            amounts of existing assets and liabilities and their  respective tax
            bases.  Deferred  tax  assets and  liabilities  are  measured  using
            enacted tax rates  expected to apply to taxable  income in the years
            in which those temporary differences are expected to be recovered or
            settled.  Under Statement 109, the effect on deferred tax assets and
            liabilities  of a change in tax rates is recognized in income in the
            period that included the enactment date.

            PRC  income  tax is  computed  according  to the  relevant  laws and
            regulations in the PRC. The Company's  subsidiaries being registered
            as a new and high technology enterprise is entitled to an income tax
            reduction.  According to the document of reductions  approved by the
            local tax bureau, the income tax rate was reduced from 33% to 15% on
            a permanent  basis.  The income tax  expenses  for the three  months
            ended March 31, 2005 and 2004 were $25,812 and $14,049 respectively.

      (L)   Foreign currency translation

            The  functional  currency  of the  Company is the  Chinese  Renminbi
            ("RMB").  Transactions  denominated in currencies other than RMB are
            translated  into United  States  dollars  using  period end exchange
            rates as to assets and liabilities and average  exchange rates as to
            revenues and  expenses.  Capital  accounts are  translated  at their
            historical exchange rates when the capital transaction occurred. Net
            gains and losses  resulting from foreign  exchange  translations are
            included in the statements of operations and stockholder's equity as
            other comprehensive income (loss). Cumulative translation adjustment
            amounts were  insignificant  at and for the three months ended March
            31, 2005 and 2004 as the RMB is pegged to the United States dollar.


                                       9
<PAGE>

      (M)   Comprehensive income

            The  foreign  currency  translation  gain  or  loss  resulting  from
            translation of the financial  statements  expressed in RMB to United
            States  Dollar  is  reported  as  other  comprehensive  loss  in the
            statements  of  operations  and  stockholders'  equity.   Cumulative
            translation  adjustment  amounts were  insignificant  at and for the
            three months ended March 31, 2005 and 2004.

      (N)   Earnings per share

            Basic earnings per share are computed by dividing  income  available
            to common  shareholders  by the  weighted  average  number of common
            shares outstanding during the period.  Diluted earnings per share is
            computed  similar  to  basic  earnings  per  share  except  that the
            denominator is increased to include the number of additional  common
            shares  that would have been  outstanding  if the  potential  common
            shares had been  issued and if the  additional  common  shares  were
            dilutive. There are no potentially dilutive securities for the three
            months ended March 31, 2005 and 2004.

            The weighted  average of shares used to compute the diluted earnings
            per  share  in  these   financial   statements   (unaudited)   would
            potentially be further diluted by 10,465,725  shares of common stock
            (post  a one for  eighteen  reverse  split)  in the  future  had the
            convertible promissory note of $1,900,000 be exercised.

      (O)   Segments

            The  Company  operates  in  only  one  segment,  thereafter  segment
            disclosure is not presented.

      (P)   Recent Accounting Pronouncements

            Statement  of  Financial  Accounting  Standards  ("SFAS")  No.  151,
            "Inventory  Costs - an amendment  of ARB No. 43,  Chapter 4 SFAS No.
            152,  "Accounting  for Real Estate  Time-Sharing  Transactions  - an
            amendment  of  FASB  Statements  No.  66  and  67,"  SFAS  No.  153,
            "Exchanges of Non-monetary  Assets - an amendment of APB Opinion No.
            29," and SFAS No. 123 (revised  2004),  "Share-Based  Payment," were
            recently issued.  SFAS No. 151, 152, 153 and 123 (revised 2004) have
            no current  applicability  to the  Company and have no effect on the
            financial statements.

2.    RESTATEMENT OF FINANCIAL STATEMENTS

      The Company  originally  recorded during the year ended December 31, 2004,
      the costs  incurred by SCRE prior to the reverse merger as expenses of the
      Company for that year.  Under reverse merger  accounting such costs should
      be treated as a reduction of additional  paid in capital.  The Company has
      restated  these  costs in the  Balance  Sheet,  Statement  of  Operations,
      Statement of Stockholders' Equity and the Statement of Cash Flows.

     A summary of significant effects of the restatement is as follows:


                                       10
<PAGE>
                                                  December 31,
                                                      2004          December 31,
                                                (As Previously        2004
Statement of Operations for the year               Reported)       (As Restated)
  ended December 31, 2004                        ------------      ------------
Net sales                                        $  2,478,763      $  2,478,763
Cost of sales                                      (2,235,189)       (2,235,189)
Gross profit                                          243,574           243,574
Operating expenses                                    964,637           465,923
Loss from operations                                 (721,063)         (222,349)
Other income (expenses)                                 1,760             1,760
Income tax expense                                     (7,503)           (7,503)
Minority interest                                       8,362             8,362
Net loss                                             (718,444)         (219,730)
Net loss per share-basic and diluted             $      (0.01)     $     (0.003)
Weighted average number of shares outstanding
     during the year-basic and diluted             81,123,434         81,123,434

                                                    December 31,
                                                      2004          December 31,
                                                (As Previously         2004
Balance sheet as of December 31, 2004              Reported)       (As Restated)
                                                 ------------      ------------
Current assets                                   $  1,971,231      $  1,971,231
Property and equipment, net                            89,503           879,503
Land use rights, net                                  133,974           133,974
Other assets                                           31,190            31,190
Total assets                                        3,015,898         3,015,898
Current liabilities                                 2,314,085         2,314,085
Minority interest                                      58,915            58,915
Stockholders' equity
     Common stock                                      93,605            93,605
     Additional paid-in capital                     3,082,105         2,583,391
     Retained earnings (deficit)
       Unappropriated                              (2,540,062)       (2,041,348)
       Appropriated                                     7,250             7,250
Total liabilities and stockholders' equity       $  3,015,898      $  3,015,898

                                                   March 31,
                                                     2005            March 31,
                                                (As Previously         2005
Balance sheet as of March 31, 2005 (unaudited)    Reported)        (As Restated)
                                                 ------------      ------------
Current assets                                   $  4,361,881      $  4,361,881
Property and equipment, net                           862,080           862,080
Land use rights, net                                  133,288           133,288
Other assets                                           31,078            31,078
Total assets                                        5,388,327         5,388,327
Current liabilities                                 2,220,801         2,220,801
Minority interest                                      56,832            56,832
Stockholders' equity
     Common stock                                      93,605            93,605
     Additional paid-in capital                     5,497,563         4,998,849
     Retained earnings (deficit)
       Unappropriated                              (2,487,724)       (1,989,010)
       Appropriated                                     7,250             7,250
Total liabilities and stockholders' equity       $  5,388,327      $  5,388,327


                                       11
<PAGE>

3.    ACCOUNTS RECEIVABLE

      Accounts  receivable at March 31, 2005  (unaudited)  and December 31, 2004
      consisted of the following:

                                                        2005
                                                     (Unaudited)         2004
                                                     ----------       ----------
      Accounts receivable                            $  504,967       $  104,144
      Less: allowance for doubtful accounts                  --               --
                                                     ----------       ----------
      Accounts receivable, net                       $  504,967       $  104,144
                                                     ==========       ==========

      As of March 31,  2005  (unaudited)  and  December  31,  2004,  the Company
      considered  all  accounts  receivable  collectable  and has not recorded a
      provision for doubtful accounts.

4.    INVENTORIES

     Inventories at March 31, 2005  (unaudited)  and December 31, 2004 consisted
of the following:

                                                        2005
                                                     (Unaudited)         2004
                                                     ----------       ----------
      Raw materials                                  $1,071,819      $1,047,781
      Work-in-progress                                   11,296          11,917
      Finished goods                                    242,252         242,327
                                                     ----------      ----------
                                                      1,325,367       1,302,025
      Less: provision of obsolescence                        --              --
                                                     ----------      ----------
                                                     $1,325,367      $1,302,025
                                                     ==========       ==========

      For the three months ended March 31, 2005  (unaudited)  and March 31, 2004
      (unaudited), the Company did not have any obsolete inventories.


5.    OTHER ASSETS

     Other assets at March 31, 2005  (unaudited) and December 31, 2004 consisted
of the following:

                                                        2005
                                                     (Unaudited)         2004
                                                     ----------       ----------
      Short-term note receivable                     $  181,159      $  181,159
      Advances to staff                                  12,509          39,227
      Prepayments                                        76,523          63,018
      Trade depostis paid                                80,059          32,590
      Others                                             20,804          19,064
                                                     ----------      ----------
                                                     $  371,054      $  335,058
                                                     ==========      ==========


                                       12
<PAGE>

6.    PROPERTY AND EQUIPMENT

      The  following  is a summary of property  and  equipment at March 31, 2005
      (unaudited) and December 31, 2004:

                                                        2005
                                                     (Unaudited)         2004
                                                     ----------       ----------
      Plant and machinery                            $  808,341      $  769,476
      Motor vehicles                                     87,262          87,262
      Furniture and office equipment                     29,047          20,251
      Construction in progress - factory building       293,883         286,039
                                                     ----------      ----------
                                                      1,218,533       1,163,028
      Less: accumulated depreciation                    356,453         283,525
                                                     ----------      ----------
      Property and equipment, net                    $  862,080      $  879,503
                                                     ==========      ==========

      Depreciation   expenses   for  the  three  months  ended  March  31,  2005
      (unaudited)  and March 31,  2004  (unaudited)  were  $72,928  and  $30,154
      respectively.

7.    INVESTMENT IN AFFILIATE

      On June 16, 2004,  the  Company's  subsidiary  Xian  Huifeng  Biochemistry
      Joint-Stock  Company Limited  ("Huifeng  Biochemistry")  acquired an 86.7%
      interest in Baoji Jinsen Pharmaceutical  Company Limited, later renamed to
      Xian Huifeng  Pharmaceutical  Company Limited ("Huifeng  Pharmaceutical"),
      which owns licenses to manufacture two pharmaceutical products in the PRC.
      The balance of 13.3% is held by a stockholder of the Company.  On November
      10, 2004 Huifeng  Pharmaceutical  increased  its  registered  capital from
      $181,159  to  $603,865.   The  increased   registered  capital  was  fully
      subscribed  by a  stockholder  of  the  Company,  diluting  the  Company's
      interest in Huifeng Pharmaceutical from 86.7% to 26%.

      A summary of the  unaudited  financial  statements  of the affiliate as of
      March 31, 2005 and December 31, 2004 is as follows:

<TABLE>
<CAPTION>
                                                                   2005               2004
                                                                -----------       -----------
<S>                                                             <C>               <C>
      Current assets                                            $   434,181       $   425,641
      Non-current assets                                          1,652,740             1,086
                                                                -----------       -----------
      Total assets                                                2,086,921           426,727
                                                                ===========       ===========
      Current liabilities                                         1,665,459             4,831
      Stockholders' equity                                          421,462           421,896
                                                                ===========       ===========
      Total liabilities and stockholders' equity                $ 2,086,921       $   426,727
                                                                ===========       ===========
      Revenue                                                   $        --       $        --
                                                                ===========       ===========
      Net loss from November 11, 2004 to December 31, 2004               --              (810)
                                                                ===========       ===========
      Net loss from January 1, 2005 to March 31, 2005                  (433)               --
                                                                ===========       ===========

      The Company's share of the loss for the period :
      Company share at 26% and equity in loss of affiliate      $      (112)      $      (211)
                                                                ===========       ===========
</TABLE>

8.    OTHER PAYABLES AND ACCRUED EXPENSES

      Other payables and accrued  liabilities at March 31, 2005  (unaudited) and
      December 31, 2004 consisted of the following:


                                       13
<PAGE>

                                                        2005
                                                     (Unaudited)         2004
                                                     ----------       ----------
      Other payables                                 $   25,152       $   24,640
      Accrued expenses                                  111,470          113,599
      Deposits received from customers                   25,850            6,952
                                                     ----------       ----------
                                                     $  162,472       $  145,191
                                                     ==========       ==========

9.    CONVERTIBLE NOTE PAYABLE

      Note payable at March 31, 2005 (unaudited) and December 31, 2004 consisted
      of the following:

                                                        2005
                                                     (Unaudited)         2004
                                                     ----------       ----------

Convertible Promissory Note                          $1,900,000       $1,900,000
                                                     ==========       ==========

      Pursuant to a Convertible  Promissory Note, the Company promises to pay to
      Shareholders or their registered assigns,  the principal sum of $1,900,000
      on June 30, 2005 or such earlier date as the Convertible  Note is required
      or permitted to be repaid as provided  hereunder the maturity date, and to
      pay  interest  to  the  Holders  on the  aggregate  unconverted  and  then
      outstanding  principal  amount of this  Convertible Note at the rate of 5%
      per annum,  payable on the  maturity  date as set forth  herein.  Interest
      shall be  calculated  on the basis of a 360 days year and shall  accrue on
      the  maturity  date.  On the maturity  date,  the Company may, in its sole
      discretion,  pay the  principal  sum by issuing  to the Holder  10,465,725
      shares of the  Company's  restricted  common  stock at $0.1815  per share,
      provided a require 1 for 18 reverse  stock  split of the common  stock has
      been effected. As of May 15, 2005, the Convertible Promissory Note has not
      been exercised.

10.   COMMITMENTS AND CONTINGENCIES

      (A)   Employee benefits

            The full time  employees  of the  Company  are  entitled to employee
            benefits  including medical care,  welfare  subsidies,  unemployment
            insurance and pension benefits through a Chinese government mandated
            multi-employer defined contribution plan. The Company is required to
            accrue  for  those  benefits  based on  certain  percentages  of the
            employees'  salaries and make  contributions to the plans out of the
            amounts  accrued  for  medical  and  pension  benefits.  The Chinese
            government is responsible  for the medical  benefits and the pension
            liability to be paid to these employees.

      (B)   Commitments

            The  Company  occupies  office  space  from a third  party  under an
            operating lease which expires on March 2006 at a quarterly rental of
            $3,080.  Accordingly,  for the three months ended March 31, 2005 and
            2004,  the Company  recognized  rental expense for this space in the
            amount of $3,080 and $3,080 respectively.

            As of March 31, 2005, the Company has outstanding  commitments  with
            respect  to  non-cancelable  operating  leases,  which  are  due  as
            follows:


            2005                                                      $    9,239
            ----                                                      ----------
            2006                                                           3,080
                                                                      $   12,319
                                                                      ==========


                                       14
<PAGE>

11.   SHAREHOLDERS' EQUITY

      (A)   Capital contribution

            During  the  three  months  ended  March  31,  2005,  the  Company's
            subsidiary  Xian Huifeng  Biochemistry  Joint-Stock  Company Limited
            ("Huifeng Biochemistry") declared a contribution of $2,415,459 to be
            used to increase its registered capital.

      (B)   Appropriated retained earnings

            The  Company's  wholly owned  subsidiary,  Huifeng  Biochemistry  is
            required to make  appropriations  to reserves funds,  comprising the
            statutory  surplus  reserve,   statutory  public  welfare  fund  and
            discretionary  surplus  reserve,   based  on  after-tax  net  income
            determined  in  accordance   with  generally   accepted   accounting
            principles  of the  People's  Republic  of China  (the "PRC  GAAP").
            Appropriation  to the statutory  surplus  reserve should be at least
            10% of the after tax net income  determined in  accordance  with the
            PRC  GAAP  until  the  reserve  is  equal  to 50%  of the  entities'
            registered  capital.  Appropriations to the statutory public welfare
            fund are at 5% to 10% of the  after  tax net  income  determined  in
            accordance  with the PRC GAAP. The statutory  public welfare fund is
            established  for the purpose of providing  employee  facilities  and
            other collective benefits to the employees and is  non-distributable
            other  than  in  liquidation.  Appropriations  to the  discretionary
            surplus  reserve  are  made  at  the  discretion  of  the  Board  of
            Directors.

12.   RELATED PARTY TRANSACTIONS

      The  Company  had  advanced  funds   totaling   $272,324  and  $62,493  to
      stockholders  as of March 31, 2005 and December 31, 2004  respectively  as
      short-term, unsecured loans free of interest payment.

      Stockholders  had also advanced funds totaling $73,868 and $193,433 to the
      Company  as of March  31,  2005 and  December  31,  2004  respectively  as
      short-term, unsecured loans free of interest payment.

      The Company had advanced funds to an associate totaling $1,665,459.

13.   CONCENTRATIONS AND RISKS

      During  the  three  months  ended  March 31,  2005 and  2004,  100% of the
      Company's assets were located in China, 79% and 93%, respectively,  of the
      Company's revenues were derived from companies located in China.

Item 2.  Management's Discussion and Analysis or Plan of Operation.

This  report  contains  forward-looking  statements  within  the  meaning of the
federal  securities  laws.  These  include  statements  about our  expectations,
beliefs,  intentions or strategies for the future, which we indicate by words or
phrases such as "anticipate,"  "expect," "intend," "plan," "will," "we believe,"
"SCRE believes," "management believes" and similar language. The forward-looking
statements  are based on the  current  expectations  of SCRE and are  subject to
certain risks,  uncertainties and assumptions,  including those set forth in the
discussion  under  "Management's  Discussion and Analysis or Plan of Operation".
The actual  results may differ  materially  from  results  anticipated  in these
forward-looking   statements.   We  base  the   forward-looking   statements  on
information  currently  available to us, and we assume no  obligation  to update
them.

On  December  20,  2004,  pursuant to an  agreement  between the Company and Art
Malone,   Jr.  (the  "Malone   Agreement"),   Art  Malone,   Jr.  (the  "Selling
Shareholder")  sold  7,229,601  shares of the common  stock of the  Company  for
$300,000  (the "Sale") to Zhi Lan Wang and Jun Lin,  individuals  on the closing
date of December 20, 2004. As a result,  the  7,229,601  shares of the Company's


                                       15
<PAGE>

common  stock sold  represented  approximately  56.18% of the total  outstanding
shares of common stock of the Company.  Immediately thereafter,  on December 20,
2004 SCRE  completed  a  Northwest  Agreement,  of which the  Company  initially
purchased 30% of the common shares of NBTI in exchange for 80,735,590  shares of
the Company's common stock ("Acquisition"). The purchase price for the remaining
70% of NBTI's common shares was $1,900,000  payable by the Company's issuance of
a promissory note ("Promissory  Note") on December 20, 2004. The Promissory Note
may be  convertible  into  10,465,725  (post a one for eighteen  reverse  split)
shares of the Company's common stock. As a result,  the 80,735,590 shares of the
Company's  common  stock  sold  represented  approximately  86.3%  of the  total
outstanding  stock of the Company.  The Exchange  resulted in a change of voting
control of the Company.

NBTI was  incorporated  in the British  Virgin  Islands on June 25,  2004.  NBTI
operates through its wholly owned subsidiary,  Huifeng  Biochemistry Joint Stock
Company ("Huifeng"), which is a joint venture company established under the laws
of  China  and is  engaged  in the  production  and  sales  of  plant  extracts,
biochemical products and pharmaceutical raw products in the PRC.

The exchange was treated as a reverse  acquisition for accounting  purposes.  As
such, the financial information reflected activity subsequent to the acquisition
for  SCRE and its  subsidiaries  and  financial  activity  of NBTI  prior to the
acquisition.  We will continue the business operations conducted by NBTI. All of
the information  contained in the discussion of the Company's operations in this
section takes into account the historical business of NBTI, not Secured Data.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

We have  identified  one policy  area as critical  to the  understanding  of our
consolidated financial statements. The preparation of our consolidated financial
statements requires management to make estimates and assumptions that affect the
reported  amounts of assets and liabilities and disclosure of contingent  assets
and  liabilities at the date of the  consolidated  financial  statements and the
reported  amounts of sales and  expenses  during  the  reporting  periods.  With
respect  to net  realizable  value  of the  Company's  accounts  receivable  and
inventories,  significant estimation judgments are made and actual results could
differ materially from these estimates.

The Company  does not have any  reserves  against  its  accounts  receivable  or
inventories at March 31, 2005 and 2004.  Management's  estimation that there are
no  reserves is based on the current  facts that there are no  significant  aged
accounts  receivable and the current inventory turnover is sufficient to realize
the  current  carrying  value of the  inventories.  In  making  their  judgment,
management has assumed that there will be continued demand for their products in
the  future,   thereby   maintaining   adequate  turnover  of  the  inventories.
Additionally,  management  has assumed that customers will continue to pay their
outstanding  invoices timely, and that their customers' financial positions will
not  deteriorate  significantly  in the  future,  which  would  result  in their
inability  to pay their debts to the  Company.  While the  Company's  management
currently  believes that there is little  likelihood  that the actual results of
their current  estimates will differ materially from its current  estimates,  if
customer demand for its products decreases  significantly in the near future, or
if the financial position of its customers  deteriorates in the near future, the
Company could realize  significant  write downs for slow moving  inventories  or
uncollectible accounts receivable.


                                       16
<PAGE>

We believe the  following is among the most  critical  accounting  policies that
impact our consolidated  financial  statements.  We suggest that our significant
accounting  policies,  as described in our consolidated  financial statements in
the Summary of Significant Accounting Policies, be read in conjunction with this
Management's  Discussion  and  Analysis of  Financial  Condition  and Results of
Operations.

We recognize  revenue in accordance with Staff  Accounting  Bulletin ("SAB") No.
104.  All of the  following  criteria  must  exist in order for us to  recognize
revenue:

      1.    Persuasive evidence of an arrangement exists;

      2.    Delivery has occurred or services have been rendered;

      3.    The seller's price to the buyer is fixed or determinable; and

      4.    Collectibility is reasonably assured.

The  majority  of the  Company's  revenue  results  from  sales  contracts  with
distributors  and revenue is generated upon the shipment of goods. The Company's
pricing  structure  is fixed  and there  are no  rebate  or  discount  programs.
Management  conducts  credit  background  checks for new customers as a means to
reduce the subjectivity of assuring collectibility.  Based on these factors, the
Company  believes  that it can  apply  the  provisions  of SAB 104 with  minimal
subjectivity.

RESULTS OF OPERATIONS

The  following  table sets forth  selected  statement  of  operations  data as a
percentage of revenues for the periods indicated.

                                               Three Months Ended
                                         March 31, 2005     March 31, 2004
                                         --------------     --------------

Revenues                                       100.00%               100%
Cost of Revenues                              (88.16%)           (86.59%)
Gross Margin                                    11.84%             13.41%
General and administrative expenses            (4.54%)            (1.65%)
Selling and distribution expenses              (1.77%)            (1.41%)
Depreciation and amortization                  (1.88%)            (2.43%)
Equity in loss of affiliate                    (0.01%)              0.00%
Interest income, net                             0.00%              0.03%
Other income (expense), net                      4.56%            (0.21%)
Income tax expenses                            (2.79%)            (2.63%)
Minority interest                                0.22%              0.40%
Net income                                       5.65%              5.50%

THREE MONTHS ENDED MARCH 31, 2005 COMPARED TO THREE MONTHS ENDED MARCH 31, 2004


                                       17
<PAGE>

Revenues, Cost of Revenues and Gross Margin

Revenues for the three months ended March 31, 2005 were $926,538, an increase of
$392,919 from $533,619 for the three months ended March 31, 2004.  Our increases
in sales  revenues in the first  quarter of 2005 over the first  quarter of 2004
were mainly attributable to the increase in our sales of Rutin related products.
The increase in demand for Rutin related products in China created a substantial
market for Rutin and  resulted in increased  sales of our Rutin  products in the
first quarter of 2005 as compared to the first quarter of 2004.

Cost of revenues  for the three months  ended March 31, 2005 were  $816,815,  an
increase of $354,729  from  $462,086  for the three months ended March 31, 2004.
Compared  to the first  quarter of 2005,  the  increase  in cost of sales of our
products  was because of our increase in sales  revenue in the first  quarter of
2005 as compared to the first quarter of 2004. However,  the increase in cost of
sales of our  products was not in the same  proportion  as our increase in sales
revenue  because our profit  margin  decreased  in the first  quarter of 2005 as
compared to the first quarter of 2004.

Our gross profit  margin for the three months ended March 31, 2005  deteriorated
from  13.4% for the  first  three  months  of 2004 to 11.8% for the first  three
months  of 2005.  This  slight  decrease  was a  result  of  slight  operational
inefficiencies  which varied from quarter to quarter during the normal course of
production.

Gross margin for the three months ended March 31, 2005 was $109,723, an increase
of $38,190 from $71,533 for the three months ended March 31, 2004.

General and Administrative Expenses

General and  Administrative  expenses totaled $42,076 for the three months ended
March 31,  2005,  an increase of $33,276  from $8,800 for the three months ended
March 31, 2004. The increase in general and  administrative  expenses was mainly
due to an increase in general and administrative expenses in Huifeng and SCRE as
a result of an increase in business activities.

Selling and Distribution Expenses

Selling and  distribution  expenses  totaled  $16,394 for the three months ended
March 31,  2005,  an increase of $8,872 from $7,522 for the three  months  ended
March 31, 2004. The Company had increased its expenses in sales and distribution
with sales revenue  increased in order to support the direct selling  activities
to industrial customers.

Liquidity and Capital Resources

Cash

Our cash balance amounted to $219,303 at March 31, 2005.

In the three months ended March 31, 2005, our cash used in operating  activities
totaled  $313,306,  mainly due to an  increase  in  accounts  receivable  in the
three-month period, which totaled $400,823 and offset the net profit of $52,338.
In the three months ended March 31, 2005, cash flow used in investing activities
totaled $55,505. Cash flow from financing activities totaled $420,603.


                                       18
<PAGE>

The Company is  currently  funding  its  operations  from,  in addition to sales
revenues, loans from shareholders.

Working Capital

Our working capital amounted to $2,141,080 at March 31, 2005.

NEW ACCOUNTING PRONOUNCEMENTS

In  January  2003,  (as  revised  in  December  2003) The  Financial  Accounting
Standards  Board ("FASB") issued  Interpretation  No. 46(R),  "Consolidation  of
Variable Interest  Entities",  an interpretation of Accounting Research Bulletin
("ARB") No. 51, "Consolidated  Financial  Statements".  Interpretation No. 46(R)
addresses  consolidation by business  enterprises of variable interest entities,
which  have  one or  both  of the  following  characteristics:  (i)  the  equity
investment  at risk is not  sufficient  to  permit  the  entity to  finance  its
activities without additional  subordinated support from other parties, which is
provided  through  other  interest  that will absorb some or all of the expected
losses  of the  entity;  (ii)  the  equity  investors  lack  one or  more of the
following essential  characteristics of a controlling  financial  interest:  the
direct or  indirect  ability to make  decisions  about the  entities  activities
through  voting  rights or  similar  rights;  or the  obligation  to absorb  the
expected  losses of the entity if they occur,  which  makes it possible  for the
entity to finance its  activities;  the right to receive the  expected  residual
returns of the entity if they occur,  which is the  compensation for the risk of
absorbing the expected losses.

Interpretation No. 46(R), as revised,  also requires expanded disclosures by the
primary  beneficiary  (as  defined)  of a  variable  interest  entity  and by an
enterprise  that holds a significant  variable  interest in a variable  interest
entity but is not the primary beneficiary. Interpretation No. 46(R), as revised,
applies to small business  issuers no later than the end of the first  reporting
period that ends after December 15, 2004.

This  effective  date includes  those  entities to which  Interpretation  46 had
previously  been  applied.   However,  prior  to  the  required  application  of
Interpretation  No. 46(R), a public entity that is a small business issuer shall
apply  Interpretation  46 or this  Interpretation  to  those  entities  that are
considered  to be  special-purpose  entities  no later than as of the end of the
first reporting period that ends after December 15, 2003.

Interpretation No. 46(R) may be applied  prospectively with a  cumulative-effect
adjustment  as of  the  date  on  which  it is  first  applied  or by  restating
previously   issued   financial   statements  for  one  or  more  years  with  a
cumulative-effect adjustment as of the beginning of the first year restated.

In May 2003,  the FASB issued SFAS No. 150,  "Accounting  For Certain  Financial
Instruments with  Characteristics of both Liabilities and Equity".  SFAS No. 150
changes the accounting for certain financial instruments with characteristics of
both liabilities and equity that, under previous  pronouncements,  issuers could
account for as equity.  The new  accounting  guidance  contained in SFAS No. 150
requires that those  instruments  be classified  as  liabilities  in the balance
sheet.

SFAS No. 150 affects the  issuer's  accounting  for three types of  freestanding
financial  instruments.  One type is mandatorily  redeemable  shares,  which the
issuing company is obligated to buy back in exchange for cash or other assets. A
second type includes put options and forward  purchase  contracts  which involve
instruments  that do or may require the issuer to buy back some of its shares in


                                       19
<PAGE>

exchange  for cash or other  assets.  The  third  type of  instruments  that are
liabilities under this Statement is obligations that can be settled with shares,
the monetary value of which is fixed, tied solely or predominantly to a variable
such as a market  index,  or varies  inversely  with the  value of the  issuers'
shares.  SFAS No.  150  does  not  apply to  features  embedded  in a  financial
instrument that is not a derivative in its entirety.

Most of the provisions of SFAS 150 are consistent  with the existing  definition
of  liabilities  in FASB  Concepts  Statement  No.  6,  "Elements  of  Financial
Statements".  The remaining provisions of this Statement are consistent with the
FASB's proposal to revise that definition to encompass certain  obligations that
a reporting entity can or must settle by issuing its own shares.  This Statement
shall be effective for financial  instruments entered into or modified after May
31, 2003 and otherwise  shall be effective at the beginning of the first interim
period  beginning  after  June  15,  2003,  except  for  mandatorily  redeemable
financial  instruments of a non-public entity, as to which the effective date is
for fiscal periods beginning after December 15, 2004.

In November 2004, the FASB issued SFAS No. 151 "Inventory Costs". This statement
amends the guidance in ARB No. 43,  Chapter 4,  "Inventory  Pricing," to clarify
the accounting for abnormal amounts of idle facility expense,  freight, handling
costs, and wasted material (spoilage). In addition, this Statement requires that
allocation of fixed  production  overhead to the costs of conversion be based on
the  normal  capacity  of the  production  facilities.  The  provisions  of this
Statement will be effective for the Company beginning in 2005.

In December  2004,  the FASB issued SFAS No.  153,  "Exchanges  of  Non-Monetary
Assets,  an Amendment  of  Accounting  Principles  Board  ("APB") No. 29".  This
statement amends APB Opinion No. 29, "Accounting for Nonmonetary  Transactions".
Earlier  guidance had been based on the principle  that exchanges of nonmonetary
assets should be based on the fair value of the assets  exchanged and APB No. 29
included certain exceptions to this principle.  However, FASB 153 eliminated the
specific exceptions for nonmonetary  exchanges with a general exception rule for
all exchanges of  nonmonetary  assets that do not have  commercial  and economic
substance.  A nonmonetary  exchange has commercial  substance only if the future
cash flows of the entity are expected to change significantly as a result of the
exchange.  This statement is effective for  nonmonetary  exchanges  occurring in
fiscal periods beginning after June 15, 2005.

In  December  2004,  the FASB  issued a revised  SFAS No.  123,  Accounting  for
Stock-Based  Compensation,  which supersedes APB opinion No. 25,  Accounting for
Stock  Issued  to  Employees,  and its  related  implementation  guidance.  This
statement requires a public entity to recognize and measure the cost of employee
services it receives in exchange for an award of equity instruments based on the
grant-date fair value of the award (with limited  exceptions).  These costs will
be  recognized  over the period  during which an employee is required to provide
service in exchange for the award - the requisite  service  period  (usually the
vesting  period).   This  statement  also  establishes  the  standards  for  the
accounting  treatment  of these  share-based  payment  transactions  in which an
entity  exchanges  its equity  instruments  for goods or services.  It addresses
transactions  in which an entity  incurs  liabilities  in exchange  for goods or
services that are based on the fair value of the entity's equity  instruments or
that may be settled by the issuance of those equity instruments.  This statement
shall be  effective  the first  interim or annual  reporting  period that begins
after  December  15,  2005 for small  business  public  entities  and  nonpublic
companies.


                                       20
<PAGE>

The  implementations  of the above  pronouncements  are not  expected  to have a
significant   effect  on  the   Company's   consolidated   financial   statement
presentation or disclosure.

INFLATION

Inflation has not had a material impact on our business.

CURRENCY EXCHANGE FLUCTUATIONS

All of the Company's  revenues and a majority of the expenses in the first three
months of 2005 were denominated  primarily in Renminbi ("RMB"),  the currency of
The  People's  Republic of China.  There can be no  assurance  that  RMB-to-U.S.
dollar  exchange rates will remain stable.  A devaluation of the RMB relative to
the U.S. dollar would  adversely  affect our business,  financial  condition and
results of operations. We do not engage in currency hedging.

Item 3.  Controls and Procedures

The Company  maintains  disclosure  controls and procedures that are designed to
ensure that information  required to be disclosed in the Company's  Exchange Act
reports is recorded, processed,  summarized and reported within the time periods
specified in the SEC's rules and forms, and that such information is accumulated
and  communicated  to the Company's  management,  including its Chief  Executive
Officer and Chief Financial Officer,  as appropriate,  to allow timely decisions
regarding  required  disclosure  based closely on the  definition of "disclosure
controls and procedures" in Rule 13a-14(c).  The Company's  disclosure  controls
and  procedures  are  designed to provide a  reasonable  level of  assurance  of
reaching the Company's desired disclosure control  objectives.  In designing and
evaluating the disclosure  controls and procedures,  management  recognized that
any controls and  procedures,  no matter how well  designed  and  operated,  can
provide only reasonable  assurance of achieving the desired control  objectives,
and management  necessarily was required to apply its judgment in evaluating the
cost-benefit  relationship of possible  controls and  procedures.  The Company's
certifying  officer has  concluded  that the Company's  disclosure  controls and
procedures are effective in reaching that level of assurance.

As of the  end of  the  period  of  this  report,  the  Company  carried  out an
evaluation,  under the supervision and with the  participation  of the Company's
management,  including the Company's Chief  Executive  Officer and the Company's
Chief Financial Officer, of the effectiveness of the design and operation of the
Company's  disclosure  controls  and  procedures.  Based on the  foregoing,  the
Company's Chief Executive Officer and Chief Financial Officer concluded that the
Company's disclosure controls and procedures were effective.

There have been no  changes  during  the  period  covered by this  report in the
Company's internal controls or in other factors that has materially affected, or
is reasonably likely to materially  affect,  the Company's internal control over
financial reporting.


                                       21
<PAGE>

PART II.  OTHER INFORMATION

Item 1.  Legal Proceedings:

We are  currently  not involved in any  litigation  that we believe could have a
material  adverse  effect on our financial  condition or results of  operations.
There is no action, suit, proceeding,  inquiry or investigation before or by any
court,  public board,  government agency,  self-regulatory  organization or body
pending or, to the knowledge of the executive  officers of our Company or any of
our subsidiaries, threatened against or affecting the Company, our common stock,
any of our  subsidiaries  or of our  Company's  or our  Company's  subsidiaries'
officers or directors in their  capacities as such, in which an adverse decision
could have a material adverse effect.

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds:

None.

Item 3.  Defaults Upon Senior Securities:

None

Item 4. Submission of Matters to a Vote of Security Holders:

On March 23, 2005,  the Board of Directors  unanimously  approved and ratified a
1:18 reverse split (the "Reverse Split") of the Company's issued and outstanding
common stock and an amendment (the "Amendment") to its Articles of Incorporation
changing  the name of the  Company  to  "Huifeng  Bio-pharmaceutical  Technology
Inc.",  subject to the approval of the Company's  stockholders.  The record date
established by the Board for purposes of  determining  the number of outstanding
shares of voting stock  entitled to vote on the Reverse  Split and the Amendment
was March 23, 2005 (the "Record Date"). On the Record Date,  stockholders owning
53,850,640  shares of Common  Stock,  or  approximately  57.5% of the issued and
outstanding shares of Common Stock, approved the Reverse Split and the Amendment
by action taken without a meeting in accordance with Nevada law. No further vote
of our stockholders was required.

As a result, the Company filed a preliminary  information  statement pursuant to
Section  14(c)  of the  Securities  Exchange  Act of 1934 on March  23,  2005 in
connection  with  the  approval  by a  majority  of the  stockholders  of (i) an
amendment to its Articles of Incorporation  effecting the Reverse Split and (ii)
the Amendment.

On the effective date of the Reverse Split the number of issued and  outstanding
shares of common stock of the Company will be reduced from a total of 93,604,958
shares which were  outstanding  on the Record Date, to  approximately  5,200,275
shares.

When filed with the Nevada  Secretary of State,  the  Amendment  will change the
name of the Company to "Huifeng Bio-pharmaceutical Technology Inc."

However, as of the date of this filing, this preliminary  information  statement
was still not approved by the Securities and Exchange Commission.


                                       22
<PAGE>

Item 5. Other Information:

None

Item 6.  Exhibits and Reports on Form 8-K

      (a)   Exhibits

3.1.  Articles of Incorporation (1) 3.2 ByLaws (1)
3.3   Certificate of Amendment to Articles of Incorporation (2)
10.1  Amended Agreement and Plan of Reorganization dated July 13, 2004 (3)
31.1  Sarbanes Oxley Section 302 Certification
31.2  Sarbanes Oxley Section 302 Certification
32.1  Sarbanes Oxley Section 906 Certification
32.2  Sarbanes Oxley Section 906 Certification

(1)  Incorporated  by  Reference  from the  registration  statement on form SB-2
     filed on or about July 28, 2000.

(2)  Incorporated by Reference from the  registrant's  quarterly  report on Form
     10-qsb for the fiscal quarter ended March 31, 2004 filed on May 17, 2004.

(3)  Incorporated  by Reference  from  registrant's  current  report on Form 8-k
     filed on August 11, 2004.

      (b)   The following reports on Form 8-K were filed:

            o     February 4, 2005 to report the  resignation of Art Malone as a
                  director.
            o     March 11, 2005 to report the Transaction.
            o     March 18, 2005 to report the change in accountant.
            o     April 7, 2005 to report the change in accountant.
            o     April 22, 2005 to report the change in accountant.
            o     May 12, 2005 to report the Transaction.

                                   SIGNATURES

Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934, as amended, the registrant has duly caused this Report to be signed
on its behalf by the undersigned, thereunto duly authorized this July 27. 2005.


                               SECURED DATA, INC.
                           By: /s/ JING AN WANG
                               -----------------------
                               Jing An Wang
                               Chief Executive Officer


                                       23